Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01836276 · ClinicalTrials.gov registry record · Phase 4
Understanding Disparities in Quitting in African American and White Smokers
A Phase 4 study, sponsored by Nikki Nollen, PhD, MA.
- Completed
- Registry status
- Phase 4
- Development phase
- 449
- Enrollment target
NCT01836276: Completed Phase 4 study, sponsored by Nikki Nollen, PhD, MA.
NCT01836276 is a Phase 4 study that has completed, run by Nikki Nollen, PhD, MA. The registered enrollment target is 449 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (13% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01836276, a Phase 4 study, has completed, sponsored by Nikki Nollen, PhD, MA.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 449 participants
- Enrollment target
Study Summary
The purpose of this study is to describe the differences in quitting smoking between African Americans (AA) and White smokers treated with varenicline.
Primary Outcome
Defined as having no cigarettes for the previous 7 days at the Week 26 visit. The recommended cut-off of 15ng/ml for salivary cotinine will be used to differentiate smokers from non-smokers.
Interventions
- DRUG Varenicline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 449 participants |
| Start Date | 2013-02 |
| Est. Completion | 2017-04 |
| Phase | Phase 4 |
What the finished NCT01836276 record still lists
NCT01836276 is an interventional study that assigns participants to a tested intervention. The registered 449 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (13% lower).
The record links to 0 conditions, and to 1 intervention - of which Varenicline is the first listed.
NCT01836276 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01836276 about?
NCT01836276 is a clinical study titled "Understanding Disparities in Quitting in African American and White Smokers". The purpose of this study is to describe the differences in quitting smoking between African Americans (AA) and White smokers treated with varenicline.
What is the current status of trial NCT01836276?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 449 participants. The study started on 2013-02. Estimated completion is 2017-04.
What interventions are being tested in trial NCT01836276?
The interventions under investigation include: Varenicline (DRUG).
Who is sponsoring clinical trial NCT01836276?
This trial is sponsored by Nikki Nollen, PhD, MA, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01836276's enrollment target sits among peer trials
449 188th of 2000 higher than 1,813 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00515060 · 450 participants
Psychophysical Studies of Cancer Therapy Pain
- NCT01257269 · 450 participants
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
- NCT03047161 · 450 participants
Electrophysiology of Fetal Arrhythmia
- NCT03269630 · 450 participants
New Orleans Pulmonary Hypertension Biobank
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia